Abeona Therapeutics Inc.

ABEO

$5.93

-0.34%

N/A-$0.02

Healthcare

Biotechnology

NASDAQ

Active Trading

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Vishwas Seshadri	President, Chief Executive Officer & Director	USD 1,518,818	—	1976	Active
Joseph Walter Vazzano	Chief Financial Officer	USD 898,465		1984	Active
Brendan O'Malley	Chief Legal Officer	USD 783,926	—	1969	Active
Carl Denny	Senior Vice President of Regulatory Affairs	—		—	Active
Gianine Esposito	Senior VP & Chief People Officer	—		—	Active
Jon Voss	Vice President & Head of Quality	—		1960	Active
Madhav Vasanthavada	Senior Vice President, Chief Commercial Officer & Head of Business Development	—	—	1979	Active
James A. Gow	SVP, Head of Clinical Development & Medical Affairs	—	—	1967	Active
Brian Kevany	Chief Technical & Scientific Officer	—		—	Active
Megan Callan	Vice President & Head of Quality	—		—	Active
Gregory Gin	Vice President of Investor Relations & Corporation Communications	—		—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-04-27	2025	Vishwas Seshadri	President President and Chief Chief Executive Officer	Founder / CEO	$662.00K	$533.33K	$2.47M	$0	$309.49K	$14.00K	$3.99M
2026-04-27	2025	Joseph Vazzano	Chief Chief Financial Officer	C-Level	$475.90K	$235.33K	$836.40K	$0	$173.23K	$14.00K	$1.73M
2026-04-27	2025	Brendan O’Malley	Chief Chief Legal Officer	C-Level	$456.44K	$150.00K	$600.00K	$0	$163.49K	$14.00K	$1.38M
2026-04-27	2024	Vishwas Seshadri	President President and Chief Chief Executive Officer	Founder / CEO	$615.38K	$533.33K	$2.04M	$0	$309.00K	$13.80K	$3.51M
2026-04-27	2024	Joseph Vazzano	Chief Chief Financial Officer	C-Level	$456.87K	$235.33K	$744.96K	$0	$183.04K	$13.80K	$1.63M
2026-04-27	2024	Brendan O’Malley	Chief Chief Legal Officer	C-Level	$438.18K	$150.00K	$492.91K	$0	$175.55K	$13.80K	$1.27M

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of ABEO

RELATIONS

Upstream

Thermo Fisher Scientific Inc. (Patheon / Brammer Bio)NYSE:TMO REGENXBIO Inc.NASDAQ:RGNXStanford University (Office of Technology Licensing)AscellaHealth (HUB Services Partner)EB Research Partnership (EBRP)EB Medical Research FoundationCell Culture & Raw Materials Suppliers (Unspecified Multiple Suppliers)Cold-Chain Logistics Partners (Unspecified)

Downstream

ZEVASKYN Qualified Treatment Centers (QTC Network)Ultragenyx Pharmaceutical Inc.NASDAQ:RAREAscellaHealthInsurance Payors (Commercial & Government)RDEB Patient Community

Proxies

Krystal Biotech Inc.NASDAQ:KRYS bluebird bio Inc.NASDAQ:BLUE Sarepta Therapeutics Inc.NASDAQ:SRPT Vertex Pharmaceuticals Inc.NASDAQ:VRTX

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer